IMMUCELL CORP /DE/

ICCC · XNAS

CIK 811641fmd_0R77KSN7XC4PM5DFQBR1H806A6Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.